» Articles » PMID: 34331103

Overexpression of the Nucleoporin Nup88 Stimulates Migration and Invasion of HeLa Cells

Overview
Publisher Springer
Date 2021 Jul 31
PMID 34331103
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Elevated expression of the nucleoporin Nup88, a constituent of the nuclear pore complex, is seen in various types of malignant tumors, but whether this overexpression contributes to the malignant phenotype has yet to be determined. Here, we investigated the effect of the overexpression of Nup88 on the migration and invasion of cervical cancer HeLa cells. The overexpression of Nup88 promoted a slight but significant increase in both migration and invasion, whereas knockdown of Nup88 by RNA interference suppressed these phenotypes. The observed phenotypes in Nup88-overexpressing HeLa cells were not due to the progression of the epithelial-to-mesenchymal transition or activation of NF-κB, which are known to be important for cell migration and invasion. Instead, we identified an upregulation of matrix metalloproteinase-12 (MMP-12) at both the gene and protein levels in Nup88-overexpressing HeLa cells. Upregulation of MMP-12 protein by the overexpression of Nup88 was also observed in one other cervical cancer cell line and two prostate cancer cell lines but not 293 cells. Treatment with a selective inhibitor against MMP-12 enzymatic activity significantly suppressed the invasive ability of HeLa cells induced by Nup88 overexpression. Taken together, our results suggest that overexpression of Nup88 can stimulate malignant phenotypes including invasive ability, which is promoted by MMP-12 expression.

Citing Articles

Advances in the understanding of nuclear pore complexes in human diseases.

Li Y, Zhu J, Zhai F, Kong L, Li H, Jin X J Cancer Res Clin Oncol. 2024; 150(7):374.

PMID: 39080077 PMC: 11289042. DOI: 10.1007/s00432-024-05881-5.


Nuclear pore dysfunction and disease: a complex opportunity.

Fare C, Rothstein J Nucleus. 2024; 15(1):2314297.

PMID: 38383349 PMC: 10883112. DOI: 10.1080/19491034.2024.2314297.


Overexpressed Nup88 stabilized through interaction with Nup62 promotes NF-κB dependent pathways in cancer.

Singh U, Bindra D, Samaiya A, Mishra R Front Oncol. 2023; 13:1095046.

PMID: 36845732 PMC: 9947638. DOI: 10.3389/fonc.2023.1095046.


In focus in HCB.

Taatjes D, Roth J Histochem Cell Biol. 2021; 156(5):405-408.

PMID: 34729665 DOI: 10.1007/s00418-021-02044-2.

References
1.
Makise M, Nakamura H, Kuniyasu A . The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype. BMC Cancer. 2018; 18(1):519. PMC: 5934895. DOI: 10.1186/s12885-018-4454-y. View

2.
Hofmann H, Hansen G, Richter G, Taege C, Simm A, Silber R . Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res. 2005; 11(3):1086-92. View

3.
Takahashi N, van Kilsdonk J, Ostendorf B, Smeets R, Bruggeman S, Alonso A . Tumor marker nucleoporin 88 kDa regulates nucleocytoplasmic transport of NF-kappaB. Biochem Biophys Res Commun. 2008; 374(3):424-30. DOI: 10.1016/j.bbrc.2008.06.128. View

4.
Vazquez-Ortiz G, Pina-Sanchez P, Vazquez K, Duenas A, Taja L, Mendoza P . Overexpression of cathepsin F, matrix metalloproteinases 11 and 12 in cervical cancer. BMC Cancer. 2005; 5:68. PMC: 1175083. DOI: 10.1186/1471-2407-5-68. View

5.
Agudo D, Gomez-Esquer F, Martinez-Arribas F, Nunez-Villar M, Pollan M, Schneider J . Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer. 2004; 109(5):717-20. DOI: 10.1002/ijc.20034. View